LAMP2 deficiency attenuates the neurodegeneration markers induced by HSV-1 infection

Neurochem Int. 2021 Jun:146:105032. doi: 10.1016/j.neuint.2021.105032. Epub 2021 Mar 27.

Abstract

Mounting evidence suggests a major role of infectious agents in the pathogenesis of sporadic Alzheimer's disease (AD). Among them, herpes simplex virus type 1 (HSV-1) infection has emerged as a major factor in the etiology of AD. HSV-1 is able to induce some of the main alterations of the disease such as hyperphosphorylation of tau protein and accumulation of amyloid-β peptide. Functional genomic analysis of a cell model of HSV-1 infection and oxidative stress developed in our laboratory revealed lysosomal system to be the main pathway altered, and the lysosome-associated membrane protein 2 (LAMP2) gene one of the most strongly modulated genes. The aim of this work is to study LAMP2 as an AD candidate gene and to investigate its role in the neurodegeneration induced by HSV-1 using a LAMP2 knockdown cell model. LAMP2 deficiency led to a significant reduction of viral DNA replication and formation of infectious particles. In addition, tau hyperphosphorylation and inhibition of Aβ secretion induced by the virus were attenuated by the absence of LAMP2. Finally, genetic association studies revealed LAMP2 genetic variants to be associated with AD risk. In summary, our data indicate that LAMP2 could be a suitable candidate to mediate the AD-like phenotype caused by HSV-1.

Keywords: Alzheimer's disease; Genetic association; HSV-1 infection; Herpesvirus; LAMP2; Lysosome; Neurodegeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / virology
  • Animals
  • Cell Line, Tumor
  • Female
  • Gene Knockdown Techniques / methods
  • Herpes Simplex / genetics
  • Herpes Simplex / metabolism*
  • Herpes Simplex / prevention & control*
  • Herpesvirus 1, Human / metabolism*
  • Humans
  • Lysosomal-Associated Membrane Protein 2 / antagonists & inhibitors
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Lysosomal-Associated Membrane Protein 2 / metabolism*
  • Male
  • Mice
  • Middle Aged
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / virology

Substances

  • Lysosomal-Associated Membrane Protein 2